- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: AZD3514
Total 70 results
-
AstraZenecaCompleted
-
AstraZenecaCompleted
-
AstraZenecaCompletedStudy to Investigate the Pharmacodynamic Effect of a Single Dose of AZD2516 in Healthy Male SubjectsRefluxNetherlands, Belgium
-
AstraZenecaCompletedAsthma, Chronic Obstructive Pulmonary Disease (COPD)Germany
-
Samsung Medical CenterWithdrawn
-
AstraZenecaCompletedAsthma | Chronic Obstructive Pulmonary Disease COPDUnited States
-
Massachusetts General HospitalUnited States Department of Defense; AstraZenecaCompletedMeningioma | Neurofibromatosis 2United States
-
AstraZenecaActive, not recruitingCOVID-19, SARS-CoV-2Japan
-
AstraZenecaParexelCompleted
-
Entasis TherapeuticsCompleted
-
AstraZenecaCompletedParkinson's DiseaseUnited States
-
AstraZenecaParexelCompletedAsthma | Chronic Obstructive Pulmonary Disease (COPD)Germany
-
Massachusetts General HospitalNational Cancer Institute (NCI); AstraZenecaActive, not recruiting
-
Samsung Medical CenterAstraZenecaTerminatedSmall Cell Lung CancerKorea, Republic of
-
AstraZenecaQuintiles, Inc.CompletedPart A Healthy Young Males and Non-fertile Female Volunteers Aged 20 to 45 Years. | Part B Healthy Young Males and Non-fertile Female Volunteers Aged 20 to 45 and Elderly Volunteers Aged 60 to 80United Kingdom
-
AstraZenecaCompletedMultiple System Atrophy, MSAUnited States, Finland, Austria, France, Sweden, United Kingdom, Italy
-
AstraZenecaCompleted
-
AstraZenecaActive, not recruiting
-
Samsung Medical CenterWithdrawnSolid TumorKorea, Republic of
-
AstraZenecaTerminatedType 2 DiabetesSweden
-
AstraZenecaCompleted
-
AstraZenecaCompleted
-
AstraZenecaCompleted
-
AstraZenecaCompletedPharmacokinetics | Safety | Pharmacodynamics of AZD7594United Kingdom
-
AstraZenecaActive, not recruiting
-
AstraZenecaParexelCompletedAsthmaUnited States, Germany, South Africa, Ukraine, Japan, Hungary, Poland, Bulgaria
-
AstraZenecaParexelCompleted
-
AstraZenecaWithdrawnCore: Relapsed or Refractory Diffuse Large B-Cell Lymphoma | Module 1: Non-GCB Diffuse Large B-Cell Lymphoma
-
AstraZenecaCompletedAsthma | Chronic Obstructive Pulmonary Disease (COPD)United States
-
AstraZenecaParexelCompleted
-
Royal Marsden NHS Foundation TrustAstraZeneca; Institute of Cancer Research, United KingdomCompletedAdvanced CancerUnited Kingdom
-
Canadian Cancer Trials GroupAstraZenecaCompletedGlioblastoma MultiformeCanada
-
AstraZenecaCompletedAdvanced Solid Tumours With Androgen Receptor Pathway as a Potential FactorUnited Kingdom, United States
-
AstraZenecaCompletedAsthma | Efficacy | SafetyGermany, Bulgaria
-
AstraZenecaActive, not recruiting
-
National Institute of Allergy and Infectious Diseases...Completed
-
AstraZenecaCompleted
-
University of Michigan Rogel Cancer CenterTerminatedProstate CancerUnited States
-
Samsung Medical CenterTerminatedCancer of StomachKorea, Republic of
-
Samsung Medical CenterTerminatedStomach NeoplasmsKorea, Republic of
-
Cambridge University Hospitals NHS Foundation TrustAstraZenecaCompleted
-
AstraZenecaCompletedAdvanced Solid MalignanciesUnited Kingdom
-
AstraZenecaCompletedParkinson's DiseaseUnited Kingdom
-
AstraZenecaParexelWithdrawn
-
Queen Mary University of LondonAstraZeneca; Cancer Research UKUnknownSquamous Cell Lung Cancer | Triple-Negative Breast Cancer | Non-squamous Cell Lung Cancer With KRAS Mutations | Non-squamous Cell Lung Cancer With Wild-type KRASUnited Kingdom
-
AstraZenecaActive, not recruitingCOVID-19, SARS-CoV-2United States, Belgium, Canada, France, Spain, Denmark, Thailand, Vietnam, Korea, Republic of, United Kingdom, Malaysia, Israel, Taiwan, Australia, Germany, Poland, Singapore, United Arab Emirates
-
Acerta Pharma BVTerminatedDLBCL | Richter SyndromeUnited Kingdom, United States
-
AstraZenecaQuintiles, Inc.CompletedSolid MalignanciesUnited Kingdom